ESR1 and breast carcinoma: By combining genomic sequencing data at high depth on mutated sites, copy number and structural variant discovery, comparisons of RNA expression to derive intrinsic subtypes, and clinical pathology markers such as Ki67 and ER Allred scores, we have generated comprehensive information about the range of changes that occur when ER+ breast cancers are subjected to oestrogen deprivation.